Small molecules targeting p53 to improve antitumor therapy

Giovanni L. Beretta; L. Gatti; V. Benedetti; P. Perego; F. Zunino

doi:10.2174/138955708785132774

Small molecules targeting p53 to improve antitumor therapy

Giovanni L. Beretta, L. Gatti, V. Benedetti, P. Perego, F. Zunino

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.

Original language	English
Pages (from-to)	856-868
Number of pages	13
Journal	Mini-Reviews in Medicinal Chemistry
Volume	8
Issue number	9
DOIs	https://doi.org/10.2174/138955708785132774
Publication status	Published - 2008

Keywords

Apoptosis
Cancer cells
Drug combination
Histone deacetylase inhibitors
Nutlins
p53
Pifithrins
Ubiquitin ligase inhibitors

ASJC Scopus subject areas

Medicine (miscellaneous)
Chemistry(all)
Pharmacology

Access to Document

10.2174/138955708785132774

Cite this

@article{4e50a4bdfe9f4fb78c4d38e42b73348a,

title = "Small molecules targeting p53 to improve antitumor therapy",

abstract = "Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.",

keywords = "Apoptosis, Cancer cells, Drug combination, Histone deacetylase inhibitors, Nutlins, p53, Pifithrins, Ubiquitin ligase inhibitors",

author = "Beretta, {Giovanni L.} and L. Gatti and V. Benedetti and P. Perego and F. Zunino",

year = "2008",

doi = "10.2174/138955708785132774",

language = "English",

volume = "8",

pages = "856--868",

journal = "Mini-Reviews in Medicinal Chemistry",

issn = "1389-5575",

publisher = "Bentham Science Publishers B.V.",

number = "9",

}

TY - JOUR

T1 - Small molecules targeting p53 to improve antitumor therapy

AU - Beretta, Giovanni L.

AU - Gatti, L.

AU - Benedetti, V.

AU - Perego, P.

AU - Zunino, F.

PY - 2008

Y1 - 2008

N2 - Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.

AB - Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.

KW - Apoptosis

KW - Cancer cells

KW - Drug combination

KW - Histone deacetylase inhibitors

KW - Nutlins

KW - p53

KW - Pifithrins

KW - Ubiquitin ligase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=50149118399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50149118399&partnerID=8YFLogxK

U2 - 10.2174/138955708785132774

DO - 10.2174/138955708785132774

M3 - Article

C2 - 18691143

AN - SCOPUS:50149118399

VL - 8

SP - 856

EP - 868

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 9

ER -

Small molecules targeting p53 to improve antitumor therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this